Radixx International Appoints John Elieson as President and CEO
ORLANDO, Fla., Oct. 04, 2017 (GLOBE NEWSWIRE) -- Radixx International, an industry-leading provider of tailored airline reservation, distribution and merchandising systems, today announced that it has appointed John Elieson as President & CEO. Ron Peri, Radixx's Founder and former CEO, will continue to serve as Chairman of Radixx's Board of Directors.
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/1e4e5090-f5a9-457c-8e2d-b61664ed2a78
Mr. Elieson will be responsible for implementing the overall strategic direction of Radixx and will oversee the company's daily operations. Prior to joining Radixx, Mr. Elieson spent 29 years at Sabre where he most recently served as Senior Vice President of Global Accounts and Traveler Experience in their Travel Network division. During his career at Sabre, Mr. Elieson has had a variety of responsibilities including leading global sales for Sabre's Airline Solutions division and leading Global Marketing and Corporate Strategy for Travelocity. The majority of Mr. Elieson's distinguished career has been spent in direct and indirect airline distribution, both offline and online.
"John is the ideal fit for Radixx as the company continues to make significant strides and grow its customer base," said Ron Peri, Founder and Chairman of Radixx International. "We are confident that John's background and relevant experience within the global travel industry, particularly as they pertain to airline solutions, will prove to be of tremendous value. We are very pleased to welcome John to Radixx and look forward to his future contributions to the company."
"John is a talented leader with a proven track record for driving growth and building highly effective teams," said Kurt R. Jaggers, a member of Radixx's Board of Directors and a Managing Director at TA Associates, which completed a significant investment in Radixx in September 2016. "We believe that John's management skills and travel sector knowledge will prove beneficial for Radixx. On behalf of the Board of Directors, I would like to sincerely thank Ron Peri for his service, passion and dedication to Radixx and its customers, partners and employees, and we look forward to his continued contributions as Chairman."
Commenting on his appointment, Mr. Elieson said, "I am thrilled and grateful to have the opportunity to join Radixx, a company that I have followed and respected for many years. As a result of the hard work of both leadership and staff, Radixx is well positioned to take advantage of its leading technology and unique value proposition to significantly grow its customer base. I am impressed with the Radixx team and am eager to work closely with them to build upon the company's strong reputation and momentum."
John Elieson Biography
John Elieson is President & CEO of Radixx International. Prior to joining Radixx, Mr. Elieson served as Senior Vice President of Global Accounts and Traveler Experience for Sabre Travel Network, a technology provider to the global travel industry. He spent nearly three decades with Sabre and its former parent company, American Airlines, in a variety of functional areas including operations, training, software development, consulting, business development, sales & account management, marketing, product development, portfolio management, pricing & revenue management, business intelligence and strategy. During his tenure, Mr. Elieson successfully led several multi-billion dollar negotiations creating significant value for all parties. He earned an MBA from Vanderbilt University and has conducted business and managed staff all over the world. Mr. Elieson serves on several boards for businesses, universities, municipalities and non-profit organizations.
About Radixx International
Radixx International, Inc., headquartered in Orlando, Florida, is now delivering its sixth-generation passenger service system, Galaxy PSS. Galaxy is the first fully web-native PSS system and can be deployed in any public or private data center. It has been certified to operate from the smallest cloud network to the largest most demanding environments. Galaxy provides a customizable, complete enterprise system that caters to the needs of hybrid, low-cost and traditional airlines, including support for interlining, code sharing and distribution through GDS. Founded in 1993 and now hosting 50 airlines on six continents, Radixx' fully integrated, cloud-based solutions support all airline business models. Radixx recently partnered with TA Associates, a leading global growth private equity firm. For more information, visit www.radixx.com.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Radixx Solutions International, Inc. via Globenewswire
Följ NASDAQ OMX
Abonnera på våra pressmeddelanden.
Senaste pressmeddelandena från NASDAQ OMX
Raven Indusries Releases CR12(TM) Field Computer18.6.2018 16:49 | Pressmeddelande
12-Inch Display With Field Planning Features Helps Farmers Save Time and Increase Efficiencies MIDDENMEER, The Netherlands, June 18, 2018 (GLOBE NEWSWIRE) -- Raven Industries (NASDAQ:RAVN) announced today the release of a new, larger field computer: the CR12(TM). Utilizing the same powerful functionality as the CR7(TM) field computer, the CR12 offers an extensive field planning feature for increased efficiencies. Built with a durable magnesium waterproof housing and a full glass capacitive touchscreen with high brightness, the CR12 also boasts a wider, 12.1-inch display. The CR12 joins the CR7 as the latest field computer in the CRX display family. This powerful operating system features easy job set-up, fewer touches and greater efficiencies - empowering the user with extraordinary data management capabilities. A simple widget concept, easily accessible settings, and ISO Universal Terminal and Task Controller capabilities make this mighty unit an affordable, plug-and-play system. Like
FPGA programming solution goes live at AEE 2018 in latest version of SLX18.6.2018 15:00 | Pressmeddelande
Silexica / FPGA programming solution goes live at AEE 2018 in latest version of SLX . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible for the content of this announcement. Industry-first solution fully explores the design space to optimize hardware/software partitioning SLX automatically inserts pragmas and rewrites code to make it High-Level Synthesis (HLS) ready Solution designed in collaboration with customers including Ricoh SAN JOSE, Calif. and COLOGNE, Germany, June 18, 2018 (GLOBE NEWSWIRE) -- Silexica will launch a new solution within SLX to support the increasing use of FPGAs for embedded computing tasks such as sensor fusion and deep learning. It has been developed in partnership with Ricoh and other customers who will use the solution for industrial automation and defense projects. The technology will be presented at Silexica's first appearance one of the world's biggest avionics exhibitions - AEE held in Munich from June 19-20. The
Immunicum AB (publ) meddelar publicering av en översiktsartikel kring ilixadencel-konceptet i Pharmaceutical Research18.6.2018 14:00 | Pressmeddelande
Pressmeddelande 18 juni 2018 Immunicum AB (publ) meddelar publicering av en översiktsartikel kring ilixadencel-konceptet i Pharmaceutical Research Immunicum AB (publ; IMMU.ST) offentliggjorde i dag online-publiceringen av en översiktsartikel av den senaste tidens utveckling inom immunonkologiforskning, med särskilt fokus på tidigare publicerade data som stöder värdet av bolagets ledande program, ilixadencel. Artikeln, med titeln "Ilixadencel - An Allogeneic Cell-Based Anticancer Immune Primer for Intratumoral Administration" publicerades on-line i Pharmaceutical Research , American Association of Pharmaceutical Scientists officiella tidskrift. Artikeln finns via följande länk https://link.springer.com/article/10.1007/s11095-018-2438-x - Det är en ära för vårt forsknings- och utvecklingsteam på Immunicum att bli erbjudna att skriva denna omfattande översikt som tar upp ilixadencels verkningsmekanism mot bakrund av de senaste upptäckterna gällande immunaktivering mot cancer. Våra preklin
Goldman Sachs and Cisco to Host Tech Talk on Data Center Networking18.6.2018 14:00 | Pressmeddelande
SAN JOSE, Calif., June 18, 2018 (GLOBE NEWSWIRE) -- Cisco will host a conference call with Goldman Sachs and Cisco's Ish Limkakeng, SVP, Product Management, Data Center Networking Group. The discussion will focus on Cisco's data center networking strategy, comprehensive portfolio, and its competitive advantage as customers seek highly secure and differentiated offerings. Interested parties can find more information on Cisco's Investor Relations website at https://investor.cisco.com. No new financial information will be discussed on this conference call. Date: Thursday, June 21, 2018 Time: 8:30 am PT / 11:30 am ET Speaker: Ish Limkakeng, SVP, Product Management, Data Center Networking Group Moderator: Goldman Sachs' Rod Hall, Managing Director Participant Dial in: Toll Free: 877-208-2954 International Number: 973-528-0056 Passcode: 201872 Replay Information (available until July 5, 2018): Toll Free: 800-332-6854 International Number: 973-528-0005 Passcode: 201872 This event will be webc
Immunicum AB (publ) Announces Publication of Scientific Review of Ilixadencel Approach in Pharmaceutical Research18.6.2018 14:00 | Pressmeddelande
Press Release 18 June 2018 Immunicum AB (publ) Announces Publication of Scientific Review of Ilixadencel Approach in Pharmaceutical Research Immunicum AB (publ; IMMU.ST) announced today the online publication of a review article providing an overview of recent developments in immuno-oncology research, specifically focusing on previously published data supporting the value of its lead program, ilixadencel. The article, titled "Ilixadencel - An Allogeneic Cell-Based Anticancer Immune Primer for Intratumoral Administration", was published in Pharmaceutical Research , the official journal of the American Association of Pharmaceutical Scientists. The article can be accessed via the following link https://link.springer.com/article/10.1007/s11095-018-2438-x "It is an honor for our research and development team at Immunicum to be invited to write this in-depth review article covering ilixadencel's mode of action in context of the most recent discoveries in anti-cancer immune activation," comme
DSM Sinochem Pharmaceuticals launches Atorvastatin film-coated tablets, expanding its finished dosage statins portfolio18.6.2018 11:23 | Pressmeddelande
Rijswijk, 18 June 2018, June 18, 2018 (GLOBE NEWSWIRE) -- Building upon its first generic finished dosage statin launch (Rosuvastatin) in January of this year, DSM Sinochem Pharmaceuticals (DSP) has this month released its fully backward-integrated, generic Atorvastatin drug product within the EU. Additional markets are scheduled to follow later in the year.Atorvastatin is used primarily in the prevention of cardiovascular disease and hyperlipidemia, commonly known as high cholesterol, the number one cause of death worldwide. Currently, statins are the most prescribed drug family globally in the fight against these potentially life-threatening conditions. Expanding statins portfolio With the launch now of Atorvastatin finished dosage formulation, coming on the heels of the successful launch of Rosuvastatin in January of 2018, DSP is actively expanding its statins drug product portfolio, realizing its aspiration of becoming a full-service generics pharmaceutical company. What sets DSP a
I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.Besök vårt pressrum